A Goemans-Williamson type algorithm for identifying subcohorts in clinical trials

arXiv — cs.LGTuesday, November 25, 2025 at 5:00:00 AM
  • An efficient algorithm has been developed to identify predominantly homogeneous subcohorts of patients from large, inhomogeneous datasets, inspired by the Goemans-Williamson rounding technique. This algorithm has been applied to the RNA microarray dataset for breast cancer, revealing a potential link between LXR over-expression and BRCA2 and MSH6 methylation levels in specific patient subcohorts.
  • This advancement is significant as it enhances the ability to systematically identify clinically relevant patient subcohorts, which can lead to more tailored and effective treatment strategies in breast cancer research and clinical trials.
  • The development of this algorithm aligns with ongoing efforts to improve cancer detection and treatment through advanced data analysis techniques, emphasizing the importance of integrating diverse datasets and predictive models to address the complexities of cancer biology and patient care.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended apps based on your readingExplore all apps
Continue Readings
Generalizable cardiac substructures segmentation from contrast and non-contrast CTs using pretrained transformers
PositiveArtificial Intelligence
A hybrid transformer convolutional network has been developed to automate the segmentation of cardiac substructures in lung and breast cancer patients using both contrast-enhanced and non-contrast CT scans. This model was trained on a diverse dataset and evaluated for accuracy against established benchmarks, demonstrating its effectiveness across varying imaging conditions.
Enhancing Breast Cancer Prediction with LLM-Inferred Confounders
PositiveArtificial Intelligence
A recent study has enhanced breast cancer prediction by utilizing large language models (LLMs) to infer the likelihood of confounding diseases such as diabetes, obesity, and cardiovascular disease from routine clinical data. This innovative approach has shown to improve the performance of Random Forest models, with notable enhancements from models like Gemma and Llama, indicating a significant advancement in predictive analytics for breast cancer.